242 related articles for article (PubMed ID: 30104797)
1. Cost-effectiveness of risk-based breast cancer screening programme, China.
Sun L; Legood R; Sadique Z; Dos-Santos-Silva I; Yang L
Bull World Health Organ; 2018 Aug; 96(8):568-577. PubMed ID: 30104797
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness evaluation of risk-based breast cancer screening in Urban Hebei Province.
Shi J; Guan Y; Liang D; Li D; He Y; Liu Y
Sci Rep; 2023 Feb; 13(1):3370. PubMed ID: 36849794
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Manchanda R; Legood R; Burnell M; McGuire A; Raikou M; Loggenberg K; Wardle J; Sanderson S; Gessler S; Side L; Balogun N; Desai R; Kumar A; Dorkins H; Wallis Y; Chapman C; Taylor R; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
J Natl Cancer Inst; 2015 Jan; 107(1):380. PubMed ID: 25435542
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
Guzauskas GF; Garbett S; Zhou Z; Spencer SJ; Smith HS; Hao J; Hassen D; Snyder SR; Graves JA; Peterson JF; Williams MS; Veenstra DL
JAMA Netw Open; 2020 Oct; 3(10):e2022874. PubMed ID: 33119106
[TBL] [Abstract][Full Text] [Related]
6. [Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai].
Wu F; Mo M; Qin XX; Fang H; Zhao GM; Liu GY; Chen YY; Cao ZG; Yan YJ; Lyu LL; Xu WH; Shao ZM
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Dec; 38(12):1665-1671. PubMed ID: 29294584
[No Abstract] [Full Text] [Related]
7. Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis.
Arrospide A; Rue M; van Ravesteyn NT; Comas M; Soto-Gordoa M; Sarriugarte G; Mar J
BMC Cancer; 2016 Jun; 16():344. PubMed ID: 27251556
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
Moore SG; Shenoy PJ; Fanucchi L; Tumeh JW; Flowers CR
BMC Health Serv Res; 2009 Jan; 9():9. PubMed ID: 19144138
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of breast cancer screening programme for women in rural China.
Sun L; Sadique Z; Dos-Santos-Silva I; Yang L; Legood R
Int J Cancer; 2019 May; 144(10):2596-2604. PubMed ID: 30367451
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of mammography screening for Chinese women.
Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
Cancer; 2007 Aug; 110(4):885-95. PubMed ID: 17607668
[TBL] [Abstract][Full Text] [Related]
11. Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer : A Cost-Effectiveness Analysis.
Shih YT; Dong W; Xu Y; Etzioni R; Shen Y
Ann Intern Med; 2021 May; 174(5):602-612. PubMed ID: 33556275
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
Geuzinge HA; Obdeijn IM; Rutgers EJT; Saadatmand S; Mann RM; Oosterwijk JC; Tollenaar RAEM; de Roy van Zuidewijn DBW; Lobbes MBI; van 't Riet M; Hooning MJ; Ausems MGEM; Loo CE; Wesseling J; Luiten EJT; Zonderland HM; Verhoef C; Heijnsdijk EAM; Tilanus-Linthorst MMA; de Koning HJ;
JAMA Oncol; 2020 Sep; 6(9):1381-1389. PubMed ID: 32729887
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
Rim SH; Allaire BT; Ekwueme DU; Miller JW; Subramanian S; Hall IJ; Hoerger TJ
Cancer Causes Control; 2019 Aug; 30(8):819-826. PubMed ID: 31098856
[TBL] [Abstract][Full Text] [Related]
14. Quality assurance target for community-based breast cancer screening in China: a model simulation.
Yang L; Wang J; Cheng J; Wang Y; Lu W
BMC Cancer; 2018 Mar; 18(1):261. PubMed ID: 29514679
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.
Pataky R; Armstrong L; Chia S; Coldman AJ; Kim-Sing C; McGillivray B; Scott J; Wilson CM; Peacock S
BMC Cancer; 2013 Jul; 13():339. PubMed ID: 23837641
[TBL] [Abstract][Full Text] [Related]
16. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
Schiller-Fruehwirth I; Jahn B; Einzinger P; Zauner G; Urach C; Siebert U
Value Health; 2017 Sep; 20(8):1048-1057. PubMed ID: 28964436
[TBL] [Abstract][Full Text] [Related]
17. Total cost-effectiveness of mammography screening strategies.
Mittmann N; Stout NK; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Yaffe MJ
Health Rep; 2015 Dec; 26(12):16-25. PubMed ID: 26676235
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of the NHS breast screening programme: life table model.
Pharoah PD; Sewell B; Fitzsimmons D; Bennett HS; Pashayan N
BMJ; 2013 May; 346():f2618. PubMed ID: 23661112
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
Pashayan N; Morris S; Gilbert FJ; Pharoah PDP
JAMA Oncol; 2018 Nov; 4(11):1504-1510. PubMed ID: 29978189
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis.
Gray E; Donten A; Karssemeijer N; van Gils C; Evans DG; Astley S; Payne K
Value Health; 2017 Sep; 20(8):1100-1109. PubMed ID: 28964442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
